Limbix is on a mission to improve mental health with accessible technology. They are building prescription digital therapeutics (PDTs) to enable doctors to prescribe digital, evidence-based, therapeutic interventions for adolescent mental health. The company's first product, SparkRx, is the first prescription digital therapeutic for adolescent depression. The diverse team of clinicians, product designers, researchers, and engineers are all focused on one thing: giving all young people access to affordable, effective behavioral health care by giving providers immediate, safe, and evidenced based treatment options they can prescribe to their patients.
The New York Times
245 Lytton Ave, STE. 350, Palo Alto, CA 94301, USA
Tel: +1 (650) 331-7300
©2020 GSR Ventures. All Rights Reserved.